KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Free Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -52.81%
Dec 31, 2025 -73.23%
Sep 30, 2025 68.48%
Jun 30, 2025 109.92%
Mar 31, 2025 -58.29%
Dec 31, 2024 -22.90%
Sep 30, 2024 155.18%
Jun 30, 2024 -19.06%
Mar 31, 2024 -34.98%
Dec 31, 2023 -11.05%
Sep 30, 2023 170.82%
Jun 30, 2023 -39.52%
Mar 31, 2023 -9.05%
Dec 31, 2022 -13.95%
Sep 30, 2022 72.95%
Jun 30, 2022 -44.11%
Mar 31, 2022 -4.76%
Dec 31, 2021 -25.20%
Sep 30, 2021 75.30%
Jun 30, 2021 -21.94%
Mar 31, 2021 18.85%
Dec 31, 2020 45.32%
Sep 30, 2020 -51.54%
Jun 30, 2020 16.29%
Mar 31, 2020 94.35%
Dec 31, 2019 -18.43%
Sep 30, 2019 25.05%
Jun 30, 2019 59.53%
Mar 31, 2019 -63.68%
Dec 31, 2018 209.48%
Sep 30, 2018 22.82%
Jun 30, 2018 -8.23%
Mar 31, 2018 8.46%
Dec 31, 2017 -40.52%
Sep 30, 2017 8.61%
Jun 30, 2017 134.39%
Mar 31, 2017 -46.83%
Dec 31, 2016 0.85%
Sep 30, 2016 497.19%
Jun 30, 2016 137.87%
Mar 31, 2016 -178.46%
Dec 31, 2015 106.55%
Sep 30, 2015 408.51%
Jun 30, 2015 -119.18%
Mar 31, 2015 28.61%
Dec 31, 2014 -52.14%
Sep 30, 2014 -15.86%
Jun 30, 2014 89.58%
Mar 31, 2014 -58.76%
Dec 31, 2013 30.25%
Sep 30, 2013 -34.21%
Jun 30, 2013 360.04%
Mar 31, 2013 -182.15%
Dec 31, 2012 -85.14%
Sep 30, 2012 335.55%
Jun 30, 2012 286.74%
Mar 31, 2012 -81.59%
Dec 31, 2011 -11.15%
Sep 30, 2011 58.39%
Jun 30, 2011 150.99%
Mar 31, 2011 -72.38%
Dec 31, 2010 13.60%
Sep 30, 2010 33.68%
Jun 30, 2010 188.96%
Mar 31, 2010 -70.82%
Dec 31, 2009 -11.96%